Preferential suppression of limbic Fos expression by intermittent hypoxia in obese diabetic mice

Neuroscience Research

Volumn 77, Issue 4, 2013, Pages 202-207

  Mukai, Takahiro ^a   Nagao, Yuki ^a   Nishioka, Satoshi ^a   Hayashi, Tetsuya ^a   Shimizu, Saki ^a   Ono, Asuka ^a   Sakagami, Yoshihisa ^a   Watanabe, Sho ^a   Ueda, Yoko ^a   Hara, Madoka ^a   Tokudome, Kentaro ^a   Kato, Ryuji ^a   Matsumura, Yasuo ^a   Ohno, Yukihiro ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Db db mice; Fos expression; Intermittent hypoxia; Limbic system; Sleep apnea

Indexed keywords

PROTEIN FOS;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CINGULATE GYRUS; CORPUS STRIATUM; DIABETIC OBESITY; FORCED SWIMMING TEST; FOREBRAIN; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; INTERMITTENT HYPOXIA; LIMBIC SYSTEM; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; OPEN FIELD TEST; OXYGEN CONCENTRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRIFORM CORTEX; THALAMUS; VENTRAL TEGMENTUM;

DB/DB MICE; FOS EXPRESSION; IH; INTERMITTENT HYPOXIA; LIMBIC SYSTEM; SA; SLEEP APNEA;

ANIMALS; ANOXIA; BRAIN; DISEASE MODELS, ANIMAL; LIMBIC SYSTEM; MALE; MICE; MICE, OBESE; PROTO-ONCOGENE PROTEINS C-FOS; SLEEP APNEA SYNDROMES;

EID: 84888313601     PISSN: 01680102     EISSN: 18728111     Source Type: Journal    
DOI: 10.1016/j.neures.2013.09.013     Document Type: Article

References (40)

1. Aloia M.S., Arnedt J.T., Davis J.D., Riggs R.L., Byrd D. Neuropsychological sequelae of obstructive sleep apnea-hypopnea syndrome: a critical review. J. Int. Neuropsychol. Soc. 2004, 10:772-785.
2. Bedard M.A., Montplaisir J., Richer F., Rouleau I., Malo J. Obstructive sleep apnea syndrome: pathogenesis of neuropsychological deficits. J. Clin. Exp. Neuropsychol. 1991, 13:950-964.
3. Beebe D.W., Groesz L., Wells C., Nichols A., McGee K. The neuropsychological effects of obstructive sleep apnea: a meta-analysis of norm-referenced and case-controlled data. Sleep 2003, 26:298-307.
4. Clark C.R., Geffen G.M., Geffen L.B. Catecholamines and attention I: animal and clinical studies. Neurosci. Biobehav. Rev. 1987, 11:341-352.
5. Coggeshall R.E. Fos, nociception and the dorsal horn. Prog. Neurobiol. 2005, 77:299-352.
6. Elmquist J.K. Hypothalamic pathways underlying the endocrine, autonomic, and behavioral effects of leptin. Int. J. Obes. Relat. Metab. Disord. 2001, 25(Suppl. 5):78-82.
7. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates 2008, 2008. Elsevier, Manhattan. third ed.
8. Greenberg G.D., Watson R.K., Deptula D. Neuropsychological dysfunction in sleep apnea. Sleep 1987, 10:254-262.
9. Hayashi T., Yamashita C., Matsumoto C., Kwak C.J., Fujii K., Hirata T., Miyamura M., Mori T., Ukimura A., Okada Y., Matsumura Y., Kitaura Y. Role of gp91phox-containing NADPH oxidase in left ventricular remodeling induced by intermittent hypoxic stress. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H2197-H2203.
10. Hayashi T., Yoshioka T., Hasegawa K., Miyamura M., Mori T., Ukimura A., Matsumura Y., Ishizaka N. Inhalation of hydrogen gas attenuates left ventricular remodeling induced by intermittent hypoxia in mice. Am. J. Physiol. Heart Circ. Physiol. 2011, 301:H1062-H1069.
11. Herrera D.G., Robertson H.A. Activation of c-fos in the brain. Prog. Neurobiol. 1996, 50:83-107.
12. Izquierdo I., Bevilaqua L.R., Rossato J.I., Bonini J.S., Medina J.H., Cammarota M. Different molecular cascades in different sites of the brain control memory consolidation. Trends Neurosci. 2006, 29:496-505.
13. Kalia M. Neurobiological basis of depression: an update. Metabolism 2005, 54(Suppl. 1):24-27.
14. Krakow B., Melendrez D., Ferreira E., Clark J., Warner T.D., Sisley B., Sklar D. Prevalence of insomnia symptoms in patients with sleep-disordered breathing. Chest 2001, 120:1923-1929.
15. Leger D., Bayon V., Laaban J.P., Philip P. Impact of sleep apnea on economics. Sleep Med. Rev. 2012, 16:455-462.
16. Ma S., Mifflin S.W., Cunningham J.T., Morilak D.A. Chronic intermittent hypoxia sensitizes acute hypothalamic-pituitary-adrenal stress reactivity and Fos induction in the rat locus coeruleus in response to subsequent immobilization stress. Neuroscience 2008, 154:1639-1647.
17. Mannarino M.R., Di Filippo F., Pirro M. Obstructive sleep apnea syndrome. Eur. J. Intern. Med. 2012, 23:586-593.
18. Marin J.M., Carrizo S.J., Vicente E., Agusti A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365:1046-1053.
19. Mark D.H., Tony J.P. The ventral basal ganglia, a selection mechanism at the crossroads of space, strategy, and reward. Prog. Neurobiol. 2010, 90:385-417.
20. Martinez M., Calvo-Torrent A., Herbert J. Mapping brain response to social stress in rodents with c-fos expression: a review. Stress 2002, 5:3-13.
21. Miwa H., Nishi K., Fuwa T., Mizuno Y. Differential expression of c-fos following administration of two tremorgenic agents: harmaline and oxotremorine. Neuroreport 2000, 11:2385-2390.
22. Morgan J.I., Curran T. Stimulus-transcription coupling in neurons: role of cellular immediate-early genes. Trends Neurosci. 1989, 12:459-462.
23. Naegele B., Thouvard V., Pepin J.L., Levy P., Bonnet C., Perret J.E., Pellat J., Feuerstein C. Deficits of cognitive executive functions in patients with sleep apnea syndrome. Sleep 1995, 18:43-52.
24. Newman A.B., Foster G., Givelber R., Nieto F.J., Redline S., Young T. Progression and regression of sleep-disordered breathing with changes in weight: the Sleep Heart Health Study. Arch. Intern. Med. 2005, 165:2408-2413.
25. Nishino S., Mignot E. Pharmacological aspects of human and canine narcolepsy. Prog. Neurobiol. 1997, 52:27-78.
26. Ohno Y. New insight into the therapeutic role of 5-HT1A receptors in central nervous system disorders. Cent. Nerv. Syst. Agents Med. Chem. 2010, 10:148-157.
27. Ohno Y., Ishihara S., Mashimo T., Sofue N., Shimizu S., Imaoku T., Tsurumi T., Sasa M., Serikawa T. Scn1a missense mutation causes limbic hyperexcitability and vulnerability to experimental febrile seizures. Neurobiol. Dis. 2011, 41:261-269.
28. Ohno Y., Okano M., Masui A., Imaki J., Egawa M., Yoshihara C., Tatara A., Mizuguchi Y., Sasa M., Shimizu S. Region-specific elevation of D1 receptor-mediated neurotransmission in the nucleus accumbens of SHR, a rat model of attention deficit/hyperactivity disorder. Neuropharmacology 2012, 63:547-554.
29. Ohno Y., Shimizu S., Harada Y., Morishita M., Ishihara S., Kumafuji K., Sasa M., Serikawa T. Regional expression of Fos-like immunoreactivity following seizures in Noda epileptic rat (NER). Epilepsy Res. 2009, 87:70-76.
30. Ohno Y., Shimizu S., Imaki J., Masui A., Tatara A. Management of antipsychotic-induced extrapyramidal motor disorders: regulatory roles of the serotonergic nervous system. Antipsychotic Drugs: Pharmacology, Side Effects and Abuse Prevention 2013, 323-338. Nova Science Publishers, Inc., New York. T.L. Schwartz, M. Topel, J.L. Menga (Eds.).
31. Pamidi S., Tasali E. Obstructive sleep apnea and type 2 diabetes: is there a link?. Front. Neurol. 2012, 3:126.
32. Packard M.G. Anxiety, cognition, and habit: a multiple memory systems perspective. Brain Res. 2009, 1293:121-128.
33. Peppard P.E., Szklo-Coxe M., Hla K.M., Young T. Longitudinal association of sleep-related breathing disorder and depression. Arch. Intern. Med. 2006, 166:1709-1715.
34. Peppard P.E., Young T., Palta M., Dempsey J., Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. J. Amer. Med. Assoc. 2000, 284:3015-3021.
35. Porcelli S., Drago A., Fabbri C., Serretti A. Mechanisms of antidepressant action: an integrated dopaminergic perspective. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:1532-1543.
36. Punjabi N.M., Polotsky V.Y. Disorders of glucose metabolism in sleep apnea. J. Appl. Physiol. 2005, 99:1998-2007.
37. Schwartz M.W., Seeley R.J., Campfield L.A., Burn P., Baskin D.G. Identification of targets of leptin action in rat hypothalamus. J. Clin. Invest. 1996, 98:1101-1106.
38. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1987, 1:133-152.
39. Vertes R.P. Interactions among the medial prefrontal cortex, hippocampus and midline thalamus in emotional and cognitive processing in the rat. Neuroscience 2006, 142:1-20.
40. Willner P. Dopamine and depression: a review of recent evidence. II. Theoretical approaches. Brain Res. 1983, 287:225-236.